Results 151 to 160 of about 83,877 (250)

Efficacy and safety of efgartigimod in the treatment of impending myasthenic crisis. [PDF]

open access: yesFront Immunol
Li N   +11 more
europepmc   +1 more source

Molecular and immunological biomarkers to predict IVIg response.

open access: yesTrends in Molecular Medicine, 2015
C. Galeotti, S. Kaveri, J. Bayry
semanticscholar   +1 more source

Therapeutic Effect of IVIG on Inflammatory Arthritis in Mice Is Dependent on the Fc Portion and Independent of Sialylation or Basophils

open access: yesJournal of Immunology, 2014
I. Campbell   +11 more
semanticscholar   +1 more source

Immunoglobulin supplementation and longer dosing intervals reduce risk of infections in patients with RRMM treated with teclistamab. [PDF]

open access: yesBlood Cancer J
Smits F   +9 more
europepmc   +1 more source

Inhibition of FcγR-mediated phagocytosis by IVIg is independent of IgG-Fc sialylation and FcγRIIb in human macrophages.

open access: yesBlood, 2014
S. Nagelkerke   +10 more
semanticscholar   +1 more source

Predictive value for intravenous immunoglobulin resistance of Kobayashi and Kawanet scores in 722 children with Kawasaki disease across diverse ethnic backgrounds (KIWI study): an international cohort study. [PDF]

open access: yesEClinicalMedicine
Mastrolia MV   +33 more
europepmc   +1 more source

Frequency and time to relapse after discontinuing 6-month therapy with IVIg or pulsed methylprednisolone in CIDP

open access: yesJournal of Neurology Neurosurgery & Psychiatry, 2014
E. Nobile-Orazio   +16 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy